Table 4.
Groups | Initial weight (gm) | Final weight (gm) | Change in body weight | Change in body weight (%) |
---|---|---|---|---|
Normal control | 210.00 ± 8.91 | 255.17 ± 678 | 45.17 ± 6.78 | +28.23 ± 3.85 |
Diabetic control | 231.17 ± 8.78 | 212.00 ± 8.42 | −19.17 ± 5.21 | −11.15 ± 2.68 |
Diabetic + glibenclamide | 218.00 ± 7.89** | 256.50 ± 8.16** | 38.50 ± 5.98** | +22.65 ± 1.08** |
Diabetic + mixture 1 | 200.84 ± 7.75* | 222.49 ± 6.78* | 21.65 ± 8.9* | +12.45 ± 2.96* |
Diabetic + mixture 2 | 220.13 ± 8.75* | 243.91 ± 5.67* | 23.78 ± 5.81* | +12.50 ± 3.86* |
Diabetic + mixture 3 | 200.17 ± 7.45** | 226.35 ± 6.02** | 26.18 ± 6.21** | +14.37 ± 1.96** |
Diabetic + mixture 4 | 205.83 ± 7.33* | 221.48 ± 7.66* | 15.65 ± 8.88* | +9.10 ± 1.23* |
Diabetic + mixture 5 | 208.87 ± 7.75* | 229.52 ± 7.88* | 20.65 ± 5.83* | +11.54 ± 1.05* |
Results expressed as mean ± SD (n = 6). Treatment was done for 21 days. The data were statistically analysed by one-way ANOVA, followed by Dunnett's t-test. *P < 0.01, **P < 0.05. P values less than 0.01 were considered more significant.